Small DMT Trial Signals Potential Depression Treatment
TL;DR Summary
A small UK Phase IIa randomized, placebo-controlled trial found that a single dose of DMT with psychotherapy significantly reduced depressive symptoms for up to three months (some participants up to six); 47% reached remission at three months. DMT appeared safe and well tolerated, but the study's small size means larger, longer trials are needed before it could become a standard depression treatment.
- Could DMT Be a New Treatment for Depression? A Small Study Says Yes Gizmodo
- A short-acting psychedelic intervention for major depressive disorder: a phase IIa randomized placebo-controlled trial Nature
- Single dose of potent psychedelic drug could help treat depression, trial shows The Guardian
- Nature Medicine Publishes Helus Pharma’s Randomized, Placebo-Controlled Phase 2a Trial of SPL026 in Major Depressive Disorder Yahoo Finance
- Psychedelic found in Amazonian brew ayahuasca shows anti-depression promise Financial Times
Reading Insights
Total Reads
0
Unique Readers
0
Time Saved
17 min
vs 18 min read
Condensed
98%
3,436 → 62 words
Want the full story? Read the original article
Read on Gizmodo